RE:RE:Zenith Update PerspectivesBDAZ, I always very much appreciate your objectivity and remarkable scientific insight. You guide a steady ship and keep us on course.
I've become somewhat too emotional in my responses and I should probably wait a week or 2 after Don presents and read other perspectives before I post.
My father was a large animal veternarian and while acedemically I studied mathematics I also studied biology for 3 years in university. I appreciate science and the wonderful complexities of living cells and species. And so I have a very crude empathy for the complexity of biochemistry and the difficulty of trials. A good friend of my son has a degree in biology and a masters in bio-engineering. He couldn't find work so he did his clinical trials certification. He explained to me the complexity of managing quality control in trials, the imprecise and difficult challenges in recruiting and other challenges. So I guess I should appreciate that zen3694 is in dosing and that there might be some hints by Q4 2016.
I guess my business discipline kicks in when I hear Don present and I expect professionalism.
That being said, I am very much long on the science and over the years this is largely due to reading your explanations of how these compounds work and the incredible post hoc analysis since June 2013.
GLTA
Toinv